Economic Impact of Non-Medical Opioid Use in the United States

October 2019

The Society of Actuaries’ Mortality and Longevity Strategic Research Committee announce the release of a new report on the economic impact of non-medical opioid use in the United States. Performed by a Milliman team led by Stoddard Davenport with Alexandra Weaver and Matt Caverly, this study estimates the total economic burden of the opioid crisis in the United States from 2015 through 2018 and projects future costs of the opioid epidemic for 2019.

Report

Economic Impact of Non-Medical Opioid Use in the United States

Podcast

Economic Impact of Non-Medical Opioid Use in the United States

Thank You

The Sponsor would like to thank the individuals who served on the Project Oversight Group

Elizabeth Arias
Jean-Marc Fix
Sam Gutterman
Gina Guzman
Al Klein, Chairperson of the Project Oversight Group
Tom Kukla
Donna Megregian
Jim Toole
Amy Whinnett
Jan Schuh, SOA Sr. Research Administrator
Ronora Stryker, SOA Sr. Practice Research Actuary

Questions Or Comments?

Give us your feedback! Take a short survey on this report. Take Survey

If you have comments or questions, please send an email to research@soa.org